Private equity firm Butterfly has signed a deal to divest a majority stake in Orgain, a plant-based functional nutrition platform, to Nestlé Health Science. The financial terms of the deal were not disclosed. Butterfly and Orgain’s Founder and CEO – Dr. Andrew Abraham will retain a significant minority stake in the company that makes protein-based […]
Nestlé has signed a deal worth $5.75 billion with KKR to acquire core brands of Bountiful, a US manufacturer of vitamins and nutritional supplements. Included in the deal are Bountiful’s brands – Nature’s Bounty, Solgar, Osteo Bi-Flex, and Puritan’s Pride and also its US private label business. Nestlé will integrate the acquired brands into Nestlé […]
Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by acquiring the remaining stake of 74.4% in the latter for about $2 billion. The deal is expected to help the Swiss conglomerate’s subsidiary Nestlé Health Science and Aimmune Therapeutics to create a global leader in the prevention […]
Nestlé Health Science (NHSc) has agreed to acquire a majority stake in Vital Proteins, a US collagen brand and a lifestyle and wellness platform that manufactures supplements, beverages, and food products. Financial terms of the deal were not disclosed. The closing of the transaction is subject to regulatory approval. Considered to be the most abundant […]
Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut allergy drug PALFORZIA (formerly AR101), has secured an additional equity investment of $200 million from Nestlé Health Science. Based in California, Aimmune Therapeutics has been focused on the development and commercialization of treatments for potentially life-threatening food […]
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma acquisition news. Financial details of the two deals have not been disclosed. The divestments are being taken up in an effort to wrap up the $63 billion AbbVie acquisition of […]